Capital Research Global Investors Purchases 433,484 Shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA)

Capital Research Global Investors grew its holdings in shares of Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 29.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,911,525 shares of the company's stock after purchasing an additional 433,484 shares during the period. Capital Research Global Investors owned approximately 6.83% of Establishment Labs worth $88,064,000 at the end of the most recent reporting period.

A number of other large investors also recently modified their holdings of the business. Portolan Capital Management LLC grew its position in Establishment Labs by 243.1% in the 4th quarter. Portolan Capital Management LLC now owns 193,991 shares of the company's stock valued at $8,937,000 after buying an additional 137,458 shares in the last quarter. Raymond James Financial Inc. bought a new position in Establishment Labs during the 4th quarter valued at $5,494,000. Federated Hermes Inc. increased its position in shares of Establishment Labs by 3.0% during the 4th quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock valued at $1,507,000 after purchasing an additional 953 shares during the period. Sit Investment Associates Inc. lifted its holdings in shares of Establishment Labs by 104.7% in the fourth quarter. Sit Investment Associates Inc. now owns 21,600 shares of the company's stock valued at $995,000 after buying an additional 11,050 shares during the period. Finally, Simplify Asset Management Inc. grew its holdings in Establishment Labs by 197.1% during the fourth quarter. Simplify Asset Management Inc. now owns 64,300 shares of the company's stock worth $2,962,000 after acquiring an additional 42,661 shares during the period. 72.91% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of analysts recently commented on ESTA shares. Stephens reiterated an "overweight" rating and issued a $52.00 target price on shares of Establishment Labs in a report on Thursday, March 6th. Needham & Company LLC assumed coverage on Establishment Labs in a report on Monday, April 14th. They set a "hold" rating for the company. Two analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $57.40.

Establishment Labs Stock Up 0.6 %

Shares of ESTA stock traded up $0.18 on Friday, reaching $29.97. 374,558 shares of the company's stock traded hands, compared to its average volume of 458,140. The company has a market capitalization of $864.51 million, a P/E ratio of -11.62 and a beta of 0.77. Establishment Labs Holdings Inc. has a 12-month low of $26.56 and a 12-month high of $60.12. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. The business's 50 day moving average price is $36.09 and its two-hundred day moving average price is $39.22.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last released its earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The business had revenue of $44.51 million for the quarter, compared to analysts' expectations of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. On average, equities analysts forecast that Establishment Labs Holdings Inc. will post -2.41 earnings per share for the current year.

Establishment Labs Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.